Gupta Manoj Kumar, Gouda Gayatri, Vadde Ramakrishna
Department of Biotechnology & Bioinformatics, Yogi Vemana University, Kadapa, 516005, Andhra Pradesh, India.
ICAR-National Rice Research Institute, Cuttack, 753 006, Odisha, India.
Curr Obes Rep. 2024 Sep;13(3):475-495. doi: 10.1007/s13679-024-00572-1. Epub 2024 Jun 8.
Since the mid-twentieth century, obesity and its related comorbidities, notably insulin resistance (IR) and type 2 diabetes (T2D), have surged. Nevertheless, their underlying mechanisms remain elusive. Evolutionary medicine (EM) sheds light on these issues by examining how evolutionary processes shape traits and diseases, offering insights for medical practice. This review summarizes the pathogenesis and genetics of obesity-related IR and T2D. Subsequently, delving into their evolutionary connections. Addressing limitations and proposing future research directions aims to enhance our understanding of these conditions, paving the way for improved treatments and prevention strategies.
Several evolutionary hypotheses have been proposed to unmask the origin of obesity-related IR and T2D, e.g., the "thrifty genotype" hypothesis suggests that certain "thrifty genes" that helped hunter-gatherer populations efficiently store energy as fat during feast-famine cycles are now maladaptive in our modern obesogenic environment. The "drifty genotype" theory suggests that if thrifty genes were advantageous, they would have spread widely, but proposes genetic drift instead. The "behavioral switch" and "carnivore connection" hypotheses propose insulin resistance as an adaptation for a brain-dependent, low-carbohydrate lifestyle. The thrifty phenotype theory suggests various metabolic outcomes shaped by genes and environment during development. However, the majority of these hypotheses lack experimental validation. Understanding why ancestral advantages now predispose us to diseases may aid in drug development and prevention of disease. EM helps us to understand the evolutionary relation between obesity-related IR and T2D. But still gaps and contradictions persist. Further interdisciplinary research is required to elucidate complete mechanisms.
自20世纪中叶以来,肥胖及其相关合并症,尤其是胰岛素抵抗(IR)和2型糖尿病(T2D)急剧增加。然而,其潜在机制仍不清楚。进化医学(EM)通过研究进化过程如何塑造性状和疾病来阐明这些问题,为医学实践提供见解。本综述总结了肥胖相关IR和T2D的发病机制和遗传学。随后,深入探讨它们的进化联系。解决局限性并提出未来研究方向旨在增强我们对这些疾病的理解,为改进治疗和预防策略铺平道路。
已经提出了几种进化假说以揭示肥胖相关IR和T2D的起源,例如,“节俭基因型”假说表明,某些在狩猎采集人群的 feast-famine 循环中帮助他们有效地将能量储存为脂肪的“节俭基因”,在我们现代的致肥胖环境中现在是适应不良的。“漂变基因型”理论表明,如果节俭基因是有利的,它们会广泛传播,但该理论提出的是遗传漂变。“行为转变”和“食肉动物联系”假说提出胰岛素抵抗是对依赖大脑的低碳水化合物生活方式的一种适应。节俭表型理论表明发育过程中基因和环境塑造了各种代谢结果。然而,这些假说中的大多数缺乏实验验证。理解为什么祖先的优势现在使我们易患疾病可能有助于药物开发和疾病预防。进化医学帮助我们理解肥胖相关IR和T2D之间的进化关系。但仍然存在差距和矛盾。需要进一步的跨学科研究来阐明完整的机制。 (注:“feast-famine”直译为“盛宴-饥荒”,结合语境可能是指食物丰富和匮乏交替的时期,这里保留英文未翻译,因为不确定更准确的中文表述。)